Explore our full content library.
Found 3 results in 2ms
Found 3 results in 2ms
Feb 12, 2026
Lonza vs WuXi Biologics: BIOSECURE Act & U.S. Manufacturing Strategy
Former Senior Business Development Executive at Lonza
Partner Interview
Lonza Group•CH•Large CapCharles River Laboratories InternationalWuXi BiologicsCatalentThermo Fisher ScientificDanaherSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseSerial AcquirerHealth CareSep 19, 2025
AGC Biologics & Western vs Chinese CDMOs
Executive at AGC Biologics
Partner Interview
AGC BiologicsWuXi BiologicsBayerLonza GroupThermo Fisher ScientificSartorius Stedim BiotechMerckPfizerCatalentSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseHealth CareFeb 13, 2025
Lonza, WuXi Biologics & CDMO Global Market: Competitive Landscape Evolution
Executive at AGC Biologics
Partner Interview
Lonza Group•CH•Large CapPfizerEli Lilly andNovo NordiskRocheWuXi BiologicsAGC BiologicsHealth CareYou've reached the end